Where does the money for office-given drugs actually go?
Medicare pays for drugs given in a doctor's office, the infusions and injections, often the expensive ones. The spending, the number of claims, the number of patients, and the maker behind each drug are all public, but the tool to look it up is built for browsing one drug at a time, not for the questions people really want answered. Made fully searchable, it shows exactly which drugs drive the cost, which are growing, and how few makers own the spending.
The tool answers one drug at a time.
The public tool holds everything you'd want, total spending, how many claims, how many patients, the average cost per claim and per patient, and the maker behind each drug. The catch is how it works: it's built to look up one drug, not to rank them, add them up, or trace a trend across years. The richest questions, the ones about which makers dominate and which drugs are growing, are exactly the ones a look-up-one-at-a-time tool can't answer.
Made fully searchable, the same information turns useful. You can rank every drug by spending, see which are growing year over year, divide spending by patients to see what each drug costs per person treated, and add spending up by maker to reveal how concentrated the bill really is. Same numbers, finally arranged so the patterns are visible.
Questions you can finally ask.
Each is a question you simply ask and get an answer to, not a three-week analysis project.
Which drugs drive the most spending?
Rank every drug by total spending to see where the money concentrates, instead of looking them up one at a time.
Which drugs are growing fastest?
Compare spending year over year across drugs to surface the ones whose cost is climbing most steeply.
What does each drug cost per patient?
Divide spending by the number of patients to compare per-person cost, separating cheap drugs given to many from expensive ones given to few.
How concentrated is spending by maker?
Add spending up by maker to see how much of the bill sits with a handful of companies.
Where do claims and spending diverge?
Compare the number of claims against the spending to find drugs given rarely but at enormous cost, the high-price specialty ones.
Which makers' lineups are growing?
Track spending by maker over time to see whose drug revenue from Medicare is expanding fastest.
What the answer pulls together.
Spending and how often
The total spending, the number of claims, and the number of patients for each office-given drug Medicare covers.
The per-person view
The average cost per claim and per patient, which tells a high-use drug apart from a high-price one.
The maker behind each drug
Which company makes each drug, so spending can be added up by company to reveal concentration.
All the office-given drug numbers are public. What's missing isn't the information, it's the ability to rank, total, and trend it, which is exactly what a fully searchable copy restores.
What people ask about this.
Why not just use the public tool directly?
Because it's built to look up a single drug, not to rank all of them, see what's growing, or add them up by maker. The information is the same, but a fully searchable copy lets you ask the across-the-board questions, top spend, fastest growth, who dominates, that the look-up tool simply can't answer in one move.
Does this cover pharmacy drugs too?
No, this is the drugs given in a doctor's office, like infusions and injections. Drugs you pick up at a pharmacy are a separate record. Keeping them apart matters, because what drives the cost and the policy questions are different for each.
How current is the answer?
It stays current on its own. When new information is published, it's already in there, so you're asking against today's picture, not a year-old extract.
Want this answered
for a specific drug?
Whether you're a payer, a market analyst, or a researcher, I can get you the exact drug-spending answer you care about.